Chronic Fatigue Limits Quality of Life in Imatinib-Treated CML Patients
A study of patients with chronic myeloid leukemia treated with imatinib found that chronic fatigue is the major factor that limits health-related quality of life.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chronic Fatigue Syndrome | Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Health | Leukemia | Study